ARS Pharmaceuticals, Inc. (SPRY)
$4.23-7.24%Close
SELLRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $420M
- Beta
- 0.88
- P/E (TTM)
- -1.97
- Short % float
- 32.85%
- Days to cover
- 16.1
- SI change
- -8.2%
- 1W
- +3.93%
- 1M
- -16.40%
- vs SPY 1W
- +2.77%
- vs SPY 1M
- -19.40%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SPRY?
- LOPJLB’s latest quantitative signal on ARS Pharmaceuticals, Inc. (SPRY) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is SPRY in?
- ARS Pharmaceuticals, Inc. (SPRY) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does ARS Pharmaceuticals, Inc. (SPRY) do?
- ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intran…